Viewing Study NCT06502860



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06502860
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-09

Brief Title: Skin-to-Skin Contact With a Sling in Primipar Mothers Who Delivered by Cesarean Section
Sponsor: None
Organization: None

Study Overview

Official Title: Skin-to-Skin Contact With a Sling in Primipar Mothers Who Delivered by Cesarean Section
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The first hours after birth are critical for the physiological and psychological adaptation process of the newborn from intrauterine to extrauterine life The World Health Organization WHO recommends skin-to-skin contact as a routine part of care to stabilize the newborns vital signs and strengthen the mother-infant bond However the rate of skin-to-skin contact in women who give birth by cesarean section is lower compared to vaginal deliveries Considering the global increase in cesarean birth rates it is necessary to develop appropriate and practical care methods for mothers and newborns who deliver by cesarean section

The literature has examined the effects of the duration of skin-to-skin contact on breastfeeding initiation neonatal hypothermia and cardiopulmonary stability However studies aimed at increasing the duration of skin-to-skin contact are limited This study compares the effects of standard skin-to-skin contact and skin-to-skin contact using a sling on the duration of skin-to-skin contact postpartum breastfeeding success and physiological weight loss of the newborn in primiparous mothers who delivered by cesarean section
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None